EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
32 hedge funds and large institutions have $4.3M invested in ESSA Pharma in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
92% less capital invested
Capital invested by funds: $52.7M → $4.3M (-$48.3M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
32
Holding in Top 10
–
Calls
$165K
Puts
$73K
Top Buyers
| 1 | +$558K | |
| 2 | +$401K | |
| 3 | +$97.8K | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$65.1K |
| 5 |
Two Sigma Investments
New York
|
+$21.7K |
Top Sellers
| 1 | -$7.31M | |
| 2 | -$7.18M | |
| 3 | -$3.76M | |
| 4 |
AC
Aldebaran Capital
Carmel,
Indiana
|
-$984K |
| 5 |
DAM
DLD Asset Management
New York
|
-$535K |
